GW Pharma turns in flat second quarter on pandemic impact

MJBizDaily
By Matt LamersAug 7, 2020, 3:11 pm298 pts
United Kingdom-based GW Pharmaceuticals posted marginal revenue growth over the previous quarter, citing challenges stemming from the COVID-19 pandemic. GW reported revenue of $121.3 million for the quarter ended June 30 – about the same as the previous period. GW’s quarterly net loss rose slightly to $8.8…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

U.S. Senate Committee To Hold Hearing On Benefits Of Psychedelics For Military Veterans 78

UFCW seeks to organize workers at Organigram 77

AGLC walks back “Proudly Alberta” cannabis price cut 63

South Park Jokes That Trump Could Reschedule Marijuana If It’s ‘Mutually Beneficial’ For Him And Industry 63

TEDCO Invests in Leading DMV Logistical Software, Health Care Tech Company 62

CRS Provides 4 Considerations for Congress to Revise 2018 Farm Bill’s Hemp Definition 37

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.